The Cigna Group stock outlook rises after strong third quarter

Published on 11/12/2026 at 13:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The Cigna Group stock remains in focus after stronger third-quarter operations. Management raised its minimum adjusted earnings outlook for 2026.

Third-Quarter Strength Lifts Outlook

The Cigna Group lifted its minimum 2026 adjusted earnings outlook to 30.60 dollars per share from 30.45 dollars.
Third-quarter revenue rose 6 percent, while adjusted earnings per share increased to 7.98 dollars from 7.83 dollars.
Cigna Healthcare earnings grew as Evernorth's pharmacy benefit performance weakened.

Cigna Group, US1255231003, Illustration mit AI erstellt.

The Cigna Group raised its full-year 2026 adjusted earnings outlook after reporting stronger third-quarter operations on November 5. The health company now expects adjusted income from operations of at least 30.60 dollars per share, up from a previous floor of 30.45 dollars. The company outlined the change in its third-quarter results release.

Revenue Growth Meets Uneven Segment Trends

Total revenue increased 6 percent year over year to 73.7 billion dollars in the quarter. Adjusted revenue reached 73.8 billion dollars, while adjusted income from operations was 2.1 billion dollars, or 7.98 dollars per share, compared with 7.83 dollars per share a year earlier.

Reported shareholders' net income fell to 1.4 billion dollars, or 5.47 dollars per share, from 1.9 billion dollars, or 6.98 dollars per share. The Cigna Group attributed the decline primarily to the absence of an after-tax gain on a business sale recorded in the year-earlier quarter, making the adjusted comparison more relevant for underlying operations.

Performance differed across the company's businesses. Cigna Healthcare adjusted revenue rose 9 percent to 11.7 billion dollars, while pretax adjusted income from operations increased 15 percent to 1.2 billion dollars. The company linked the improvement primarily to higher net investment income and better operating efficiency.

Evernorth Health Services delivered 63.8 billion dollars in adjusted revenue, up 6 percent, but pretax adjusted income from operations declined 4 percent to 1.8 billion dollars. Pharmacy Benefit Services earnings fell 22 percent, reflecting large client contract renewals and strategic investments. Specialty and Care Services earnings rose 15 percent, supported by organic growth and greater use of biosimilar and specialty generic medicines.

Guidance Keeps Medical Costs In Focus

The revised outlook includes at least 6.9 billion dollars in pretax adjusted income from Evernorth and at least 4.6 billion dollars from Cigna Healthcare, with the latter forecast increased by 50 million dollars. Management narrowed its expected Cigna Healthcare medical care ratio range to 84.2 percent plus or minus 25 basis points, while retaining the prior midpoint.

Management said the quarter demonstrated progress in its strategy to make health care more affordable and personalized. Chief Executive Brian Evanko also pointed to the multi-year Accelerate to One modernization and productivity program, which carries a 3 billion dollar investment and is intended to reduce costs and support longer-term earnings growth.

Investors will continue to monitor pharmacy benefit contract renewals, medical-cost trends and the planned January 2027 exit from Cigna Healthcare's individual and family plans business. The company said the exit is expected to have a limited effect on the quarter's reported results but remains relevant to the future mix of its health insurance operations.

Market context: The S&P 500 provides the broader U.S. equity-market backdrop for health-insurance investors.

The Cigna Group stock traded at 272.35 euros on Lang & Schwarz at 13:29 CET on Thursday, November 12, 2026.